CompletedNCT00802100
Comparing antipsychotic treatment plans for adults with schizophrenia
About this title
Read the official source — NCT00802100Medication studyAges 18–40United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 40 years.
What did participation involve?
The protocol includes: Completing questionnaires.
- Listed locations
- Colton and 12 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateDecember 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 21
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT00802100
- Official title
Show the full official title
Comparison of Optimal Antipsychotic Treatments for Schizophrenia Pilot Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Colton · Palo Alto · New Haven
10 more locations
- Miami
- Augusta
- Glen Burnie
- Worcester
- Detroit
- Minneapolis
- New York
- Butner
- Dallas
- Houston
Interested in joining this study?
Questions about this study
What did participation involve?
The protocol called for participants to complete questionnaires.
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including Olanzapine, Perphenazine, Aripiprazole, Metformin, Simvastatin and Benztropine.
Who was this study for?
Listed age limits: 18 years to 40 years.
